uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Sprimeo
Withdrawn
Human
Details
EMA number
EMEA/H/C/000851
ATC code
C09XA02
Authorisation
22 August 2007
Withdrawn
4 July 2012
Revision
5
EMA page
Therapeutic indication
Treatment of essential hypertension.
MeSH:
Hypertension
Group:
Agents acting on the renin-angiotensin system
Active substances
aliskiren
Marketing Authorisation Holder
Novartis Europharm Ltd
MAH
Timeline
Filter by authority:
EMA
Sprimeo withdrawn
4 Jul 2012
withdrawn
regulatory
Sprimeo authorised
22 Aug 2007
authorised
regulatory
Sprimeo | uMedical